Enhancing the in vitro and in vivo activity of itraconazole against breast cancer using miltefosine-modified lipid nanocapsules

Itraconazole (ITC), a well-tolerated antifungal drug, exerts multiple anticancer effects which justified its preclinical and clinical investigation as potential anti-cancer agent with reduced side effects. Enhancement of ITC anti-cancer efficacy would bring valuable benefits to patients. We propose...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Sheridy, Nabila A., El-Moslemany, Riham M., Ramadan, Alyaa A., Helmy, Maged W., El-Khordagui, Labiba K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131005/
https://www.ncbi.nlm.nih.gov/pubmed/33960245
http://dx.doi.org/10.1080/10717544.2021.1917728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131005/
https://www.ncbi.nlm.nih.gov/pubmed/33960245
http://dx.doi.org/10.1080/10717544.2021.1917728

Ejemplares similares